SENSEX
NIFTY
GOLD
USD/INR

Weather

image 26    C

Economy News

The Economic Times

Economy / The Economic Times

details

Wegovy, Ozempic regain weight as Indian generics fall behind

Novo Nordisk's weight-loss drugs are regaining market share from Indian generics. Innovator brands show steady month-on-month sales growth, unlike generics. Eli Lilly's tirzepatide brands also experienced sales growth in the recent period. Doctors prefer innovator semaglutide due to similar pricing and pioneering status. The crowded generic market is causing brands to lose their individual market share.

9 Jul 2026 12:43 am